Edition:
United States

Taisho Pharmaceutical Holdings Co Ltd (4581.T)

4581.T on Tokyo Stock Exchange

9,110JPY
27 Mar 2017
Change (% chg)

¥-20 (-0.22%)
Prev Close
¥9,130
Open
¥9,110
Day's High
¥9,170
Day's Low
¥9,100
Volume
138,500
Avg. Vol
104,983
52-wk High
¥12,480
52-wk Low
¥8,390

Latest Key Developments (Source: Significant Developments)

Vietnam's Dhg Pharmaceutical says Q2 net profit down 1.3 pct y/y
Wednesday, 20 Jul 2016 05:34am EDT 

Dhg Pharmaceutical Joint-Stock Co : Vietnam's Dhg Pharmaceutical Co says Q2 net profit down 1.3 percent y/y at 147 billion dong ($6.6 million) Further company coverage: [DHG.HM] (Reporting By Mai Nguyen) ((mai.nguyen@thomsonreuters.com;)).  Full Article

Taisho Pharmaceutical Holdings unit signs agreement regarding allergic disease therapeutic agent
Thursday, 14 Jul 2016 10:59pm EDT 

Taisho Pharmaceutical Holdings Co Ltd <4581.T>:Says its unit Taisho Pharmaceutical signed agreement (contract for the license and commercialization) for an allergic disease therapeutic agent regarding OTC drugs in Japan with Bayer Yakuhin, Ltd., on July 11.  Full Article

Taisho Pharmaceutical Holdings unit buys shares of Duoc Hau Giang Pharmaceutical JSC
Tuesday, 5 Jul 2016 02:41am EDT 

Taisho Pharmaceutical Holdings Co Ltd <4581.T>: Says its unit acquired 24.5 percent stake in Vietnam-based co Duoc Hau Giang Pharmaceutical JSC on July 4 .Says Duoc Hau Giang Pharmaceutical JSC engaged in Pharmaceutical manufacturing and sale, sale of functional food.  Full Article

TAISHO PHARMACEUTICAL HOLDINGS raises consolidated mid-year outlook for FY 2016
Tuesday, 20 Oct 2015 02:00am EDT 

TAISHO PHARMACEUTICAL HOLDINGS Co Ltd:Says the company increased the consolidated mid-year outlook for revenue to 146,000 mln yen from 144,000 mln yen, for the fiscal year ending March 2016.Operating profit forecast increased to 13,900 mln yen from 10,000 mln yen.Ordinary profit forecast increased to 17,700 mln yen from 14,000 mln yen.Net profit forecast increased to 11,300 mln yen from 8,500 mln yen.Earnings per share increased to 139.39 yen from 104.86 yen.Comments improvements in core business and cost reduction are the main reasons for the forecast.  Full Article

TAISHO PHARMACEUTICAL HOLDINGS receives announces approval of percutaneous absorption-type analgesic anti-inflammatory agent in Japan
Monday, 28 Sep 2015 01:30am EDT 

TAISHO PHARMACEUTICAL HOLDINGS Co Ltd:Obtained the marketing approval of its percutaneous absorption-type analgesic anti-inflammatory agent for treatment of analgesic, anti-inflammatory in osteoarthritis in Japan.  Full Article

TAISHO PHARMACEUTICAL HOLDINGS issues consolidated full-year outlook for FY 2016 below Thomson Reuters I/B/E/S Estimates
Tuesday, 12 May 2015 11:30pm EDT 

TAISHO PHARMACEUTICAL HOLDINGS Co Ltd:Sees full-year revenue to be 295,000 million yen for FY ending March 31, 2016.Sees full-year operating profit of 27,000 million yen.Sees full-year ordinary profit of 35,000 million yen.Sees full-year net profit of 22,000 million yen.Sees full-year earnings per share of 271.42 yen.FY 2016 revenues of 297.28 billion yen, net income of 25.81 billion yen – Thomson Reuters I/B/E/S.  Full Article

More From Around the Web